| |
| |
|
| Insider
Information: |
Franchi Jean M. |
| Relationship: |
|
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
247,186 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,987,079 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
247,186 |
|
|
| Total
Value |
$1,987,079 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
2
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 36.7%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Dimension Therapeutics, Inc. |
DMTX |
|
|
0 |
|
0 |
Premium* |
|
|
Merrimack Pharmaceuticals Inc |
MACK |
|
|
0 |
|
0 |
Premium* |
|
|
Replimune Group Inc |
REPL |
Chief Financial Officer |
2023-05-16 |
128,748 |
2020-12-14 |
0 |
Premium* |
|
|
Biodesix Inc |
BDSX |
|
2023-08-03 |
81,772 |
2022-03-31 |
0 |
Premium* |
|
|
Disc Medicine, Inc |
IRON |
|
2024-02-07 |
36,666 |
2024-02-07 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
12 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| IRON |
Disc Medicine, Inc |
Chief Financial Officer |
• – – |
2024-02-07 |
4 |
A |
$0.00 |
$0 |
D/D |
36,666 |
36,666 |
0 |
- |
|
| BDSX |
Biodesix Inc |
|
• • – |
2023-08-03 |
4 |
A |
$1.62 |
$99,999 |
D/D |
61,728 |
81,772 |
0 |
- |
|
| REPL |
Replimune Group Inc |
Chief Financial Officer |
• – – |
2023-05-16 |
4 |
S |
$18.05 |
$204,886 |
D/D |
(11,351) |
128,748 |
0 |
% |
|
| REPL |
Replimune Group Inc |
Chief Financial Officer |
• – – |
2022-05-16 |
4 |
S |
$14.59 |
$50,131 |
D/D |
(3,436) |
95,099 |
0 |
% |
|
| REPL |
Replimune Group Inc |
Chief Financial Officer |
• – – |
2022-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
52,500 |
98,535 |
0 |
- |
|
| BDSX |
Biodesix Inc |
|
• • – |
2022-03-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
20,044 |
20,044 |
0 |
- |
|
| REPL |
Replimune Group Inc |
Chief Financial Officer |
• – – |
2021-01-14 |
4 |
AS |
$44.00 |
$663,465 |
D/D |
(14,900) |
0 |
0 |
% |
|
| REPL |
Replimune Group Inc |
Chief Financial Officer |
• – – |
2021-01-14 |
4 |
OE |
$14.08 |
$209,792 |
D/D |
14,900 |
14,900 |
0 |
- |
|
| REPL |
Replimune Group Inc |
Chief Financial Officer |
• – – |
2021-01-13 |
4 |
AS |
$44.19 |
$4,419 |
D/D |
(100) |
0 |
0 |
% |
|
| REPL |
Replimune Group Inc |
Chief Financial Officer |
• – – |
2021-01-13 |
4 |
OE |
$14.08 |
$1,408 |
D/D |
100 |
100 |
0 |
- |
|
| REPL |
Replimune Group Inc |
Chief Financial Officer |
• – – |
2020-12-14 |
4 |
AS |
$42.09 |
$1,086,200 |
D/D |
(25,000) |
0 |
0 |
% |
|
| REPL |
Replimune Group Inc |
Chief Financial Officer |
• – – |
2020-12-14 |
4 |
OE |
$14.08 |
$352,000 |
D/D |
25,000 |
25,000 |
0 |
- |
|
12 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
